Role of lymph node dissection in primary surgery for thyroid cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 5, Issue 6, 2007, Pages 623-630

  Grubbs, Elizabeth G ^a   Evans, Douglas B ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lymph node dissection; Preoperative ultrasonography; Thyroid carcinoma

Indexed keywords

ALGORITHM; ARTICLE; CANCER STAGING; ECHOGRAPHY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PREOPERATIVE EVALUATION; RECURRENCE RISK; RISK ASSESSMENT; THYROID CANCER; THYROIDECTOMY;

EID: 34447305744     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2007.0053     Document Type: Article

References (42)

1. Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 2006;107:2134-2142.
2. Frazell EL, Foote FW Jr. Papillary cancer of the thyroid; a review of 25 years of experience. Cancer 1958;11:895-922.
3. Cody HS III, Shah JP. Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan-Kettering Cancer Center. Am J Surg 1981;142:480-483.
4. Mizuno S, Funahashi H, Sugiura H, et al. [Study on extensive lymph node dissection: metastatic lymph nodes in papillary carcinoma of the thyroid], Nippon Geka Gakkai Zasshi 1986;87:883-888 [in Japanese].
5. Tisell LE, Nilsson B, Molne J, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996;20:854-859.
6. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-518.
7. Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-1138.
8. Rossi RL, Cady B, Silverman ML, et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-622.
9. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 1998;83:2638-2648.
10. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 2002;113:241-260.
11. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-1463.
12. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-142.
13. Morton DL, Cochran AJ. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol 2004;151:308-319.
14. Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288-292.
15. Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868-2874.
16. Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur Arch Otorhinolaryngol 2003;260:364-368.
17. Rubello D, Pelizzo MR, Al-Nahhas A, et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol 2006;32:917-921.
18. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-758.
19. Kouvaraki MA, Shapiro SE, Lee JE, et al. Surgical management of thyroid carcinoma. J Natl Compr Canc Netw 2005;3:458-466.
20. Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg 2001;88: 1241-1244.
21. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22-28.
22. Baatenburg de Jong RJ, Rongen RJ, Lameris JS, et al. Metastatic neck disease. Palpation vs ultrasound examination. Arch Otolaryngol Head Neck Surg 1989;115:689-690.
23. Bruneton JN, Roux P, Caramella E, et al. Ear, nose, and throat cancer: ultrasound diagnosis of metastasis to cervical lymph nodes. Radiology 1984;152:771-773.
24. Frasoldati A, Pesenti M, Gallo M, et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003;97:90-96.
25. Sherman SI, Angelos P, Ball DW, et al. The NCCN thyroid carcinoma clinical practice guidelines in oncology, version 1.2006. Available at: http://www.nccn.org/professionals/physician_gls/default.asp. Accessed May 17, 2007.
26. Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134:946-954; discussion 954-955.
27. Hodgson DC, Brierley JD, Tsang RW, Panzarella T. Prescribing 131 Iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay. Radiother Oncol 1998;47:325-330.
28. Moley JF, Wells SA. Compartment-mediated dissection for papillary thyroid cancer. Langenbecks Arch Surg 1999;384:9-15.
29. British Thyroid Association. Guidelines for the management of thyroid cancer in adults. London: Royal College of Physicians; 2006. Available at http://www.british-thyroid-association.org/draft_thyca_23.12.06.pdf. Accessed May 17, 2007.
30. Franklyn JA. Comparing USA and UK guidelines for the management of differentiated thyroid carcinoma. Thyroid 2006;16:105-107.
31. Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 2005;6: 311-322.
32. Bhattacharyya N. Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:1101-1104.
33. Musacchio MJ, Kim AW, Vijungco JD, Prinz RA. Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg 2003;69:191-196; discussion 196-197.
34. Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559-567; discussion 567-558.
35. Henry JF, Gramatica L, Denizot A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998;383:167-169.
36. Dralle H, Damm I, Scheumann GF, et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 1994;24:112-121.
37. Moley JF, Dilley WG, DeBenedetti MK. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 1997;225:734-740; discussion 740-733.
38. Weber T, Schilling T, Frank-Raue K, et al. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 2001;130:1044-1049.
39. Evans DB, Shapiro SE, Cote GJ. Invited commentary: medullary thyroid cancer: the importance of RET testing. Surgery 2007;141: 96-99.
40. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86: 5658-5671.
41. Cheah WK, Arici C, Ituarte PH, et al. Complications of neck dissection for thyroid cancer. World J Surg 2002;26:1013-1016.
42. Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 2004;130: 1214-1216.